Chemoinformaics analysis of beta-Fenchyl acetate
| Molecular Weight | 280.32 | nRot | 0 |
| Heavy Atom Molecular Weight | 260.16 | nRig | 17 |
| Exact Molecular Weight | 280.131 | nRing | 3 |
| Solubility: LogS | -2.414 | nHRing | 1 |
| Solubility: LogP | 1.148 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 42.3959 |
| nHD | 2 | BPOL | 23.5361 |
| QED | 0.645 |
| Synth | 4.914 |
| Natural Product Likeliness | 2.256 |
| NR-PPAR-gamma | 0.225 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.023 |
| Pgp-sub | 0.176 |
| HIA | 0.01 |
| CACO-2 | -4.87 |
| MDCK | 0.000027 |
| BBB | 0.897 |
| PPB | 0.442347 |
| VDSS | 0.715 |
| FU | 0.70043 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.504 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.476 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.063 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.076 |
| CYP3a4-inh | 0.037 |
| CYP3a4-sub | 0.412 |
| CL | 8.577 |
| T12 | 0.309 |
| hERG | 0.001 |
| Ames | 0.012 |
| ROA | 0.871 |
| SkinSen | 0.174 |
| Carcinogencity | 0.052 |
| EI | 0.047 |
| Respiratory | 0.938 |
| NR-Aromatase | 0.375 |
| Antiviral | Yes |
| Prediction | 0.732148 |